Chairman's
Statement
For the Year
Ended 31st December 2023
Introduction
The Company focused on two key activities during
the financial year ended 31st December 2023 - the disposal of its
formerly wholly-owned subsidiary IM Minerals Limited ("IM
Minerals") and engagement with a target company to acquire it
through a reverse takeover. Both of these activities, which
are considered to be vital steps in the relaunch of Pathfinder, are
detailed further below.
Successful
disposal of IM Minerals Limited and transition to AIM Rule 15 Cash
Shell
Following completion of the disposal of IM
Minerals on 18 August 2023 ("Completion"), Pathfinder received an
initial consideration of £1.0 million. The purchaser of IM
Minerals, Acumen Advisory Group LLC ("Acumen"), undertook to
commence legal proceedings against the Government of Mozambique in
respect of the expropriation of Mining Concession 4623C (the
"Claim") within three months of completion of the disposal of IM
Minerals by Pathfinder, a deadline subsequently extended by mutual
agreement to January 2024. Acumen filed the request for arbitration
in January 2024. Acumen has assigned the Claim to Luangwa Resources
LLC ("Luangwa"). Pathfinder management have met with
Luangwa's principals and are satisfied of their intentions to
finalise and/or settle the claim within five years.
In the event of a successful outcome of the
Claim, Pathfinder will receive a contingent payment to be made by
Acumen of a share of the aggregate amount (including all deferred
or conditional payments) payable on settlement or determination of
the Claim less all reasonable costs and expenses properly incurred
in respect of the Claim ("Contingent Payment"). The share of the
net proceeds due to Pathfinder varies on a sliding scale from 40%
to 22.5%, with Pathfinder entitled to 22.5% in the event that the
amount awarded under the Claim is above US$120 million. As reported
in the Company's announcement on 10 December 2021, the valuation
ranges prepared by Versant Partners LLC reflect a minimum of US$110
million for an ex-ante damages award, through to US$1,500 million
for an ex-post damages award.
To ensure that shareholders on Pathfinder's
share register at around the time of Completion ("Eligible Shareholders") may in due
course be compensated for the expropriation of Mining Concession
4623C, the Company intends to enter into a deed of assignment with
a Special Purpose wholly owned subsidiary of the Company
("SPV") into which any
Contingent Payment will be paid and then distributed to
shareholders of the SPV. Eligible shareholders of Pathfinder are
those who were on the Company's register as at 6:00pm on the record
date of 5 September 2023, further details of which were announced
by Pathfinder on 1 September 2023.
Following Completion, the Company ceased to own,
control, or conduct all or substantially all its previous trading
business, activities or assets and on 18 August 2023 became an AIM
Rule 15 cash shell pursuant to the AIM Rules for Companies
("AIM Rules"). As such, the
Company is required to make an acquisition or acquisitions which
constitutes a reverse takeover under AIM Rule 14 ("Reverse Takeover" (including seeking a
re-admission as an investing company (as defined under the AIM
Rules)), on or before the date falling six months from Completion
and be re-admitted to trading on AIM as an investing company under
the AIM Rules (which requires the raising of at least £6
million), failing which the Company's ordinary shares would then be
suspended from trading on AIM pursuant to AIM Rule 40.
On 29 November 2023, Pathfinder announced¸
inter alia, into
non-binding heads of terms regarding a potential acquisition of the
entire issued share capital and to be issued share capital of Rome
Resources Ltd ("Rome Resources"), which would constitute a reverse
takeover under the AIM Rules (together the "Proposed Acquisition").
Rome Resources is a tin explorer active in the Democratic Republic
of Congo and is a company in which Mark Gasson is also a director
of. The Proposed Acquisition constitutes a reverse takeover under
rule 14 of the AIM Rules. Therefore, the Proposed Acquisition would
be subject, inter alia, to
the approval of the Company's shareholders. In accordance with rule
14 of the AIM Rules, the Company's ordinary shares was suspended
from trading on AIM with effect from 7:30 a.m. on 29 November 2023.
The Company's ordinary shares will remain suspended until such time
as either an admission document is published, or an announcement is
released confirming that the Proposed Acquisition is not
proceeding. Details of Rome Resources and its assets are set out
below along with the outline terms of the proposed Reverse
Acquisition.
Rome Resources
Tin Project
Rome Resources holds majority indirect
beneficial interests in two permits (totalling 38.4km2)
in the eastern part of the Democratic Republic of Congo ('DRC'),
collectively the Bisie Tin Project, where initial surface sampling
and limited drilling to date has identified encouraging grades of
tin, copper, silver and zinc in two prospects. The mineralisation
is contained in early PalaeoProterozoic metamorphics (amphibolite
schists) with the mineralising fluids believed to be associated
with MesoProterozoic and later granite emplacement.
The project lies only 8km along trend from the
Alphamin's Mpama tin mine, which currently produces currently 4% of
global tin production (with plans to increase to 7%) associated
with the margins of the same large granitic mass. Rome
Resources has encountered grades of up to 12.8% tin, 7.8% copper,
4.2% zinc and >100ppm silver in its core samples. Two large
surface anomalies have been identified on the permits, the size of
which is comparable, if not larger, than the Alphamin
deposits.
Rome Resources' forward programme consists of
further drilling on both anomalies to delineate a tin resource by
end 2024. The continuity of this programme is important and it was
therefore agreed to loan Rome the necessary funds to continue
drilling, as detailed below.
Outline Terms
for the Proposed Acquisition
The Proposed Acquisition constitutes a
reorganization under Part 8 of Policy 5.3 of the TSX Venture
Exchange ("TSX-V"). Related to the Proposed Acquisition, Pathfinder
has agreed to lend the Company up to C$2,500,000 paid in two
drawdowns on an unsecured basis to support its ongoing exploration
activities in the DRC. The TSX Venture Exchange ("TSXV") has
conditionally accepted for filing the loan between the Company and
Pathfinder. The first drawdown of C$500k loan funds was drawn down
at year end.
Under the non-binding heads of terms governing
the Proposed Acquisition, a loan has been provided to Rome
Resources to support its early 2024 drilling programme in a tin and
related metals prospect in the Bisie North area of the North Kivu
district of the DRC. The terms of this loan facility are a
maximum facility of C$2,500,000 which, when fully drawn down post
year end, which trigged the issue of 10,000,000 warrants in Rome
Resources to the Company, exercisable at C$0.25 per share. A
fixed payment of 10% is attached to the loan, except in the case of
termination, when it will be 15%. The loan becomes repayable to the
Company on the first anniversary of full drawdown, i.e.
12th January 2025.
The Company is pleased with the
progress made to date in relation to the Proposed Acquisition and
all advisers are continuing to work hard on the proposed
transaction to bring it to fruition.
Financial results and current financial
position
As of 31 December 2023, cash and
equivalents was £1,396,000 (2023: £46,000), primarily a result of a
combination of the proceeds of £1 million from the disposal of IM
Minerals and a placing undertaken in December 2023 to raise
£1,275,000 before expenses. There was an earlier equity raise
in January 2023 of £0.5 million to provide working capital for the
Company throughout 2023. There were no operating revenues
during the reporting period.
It should be noted that immediately
following the end of the reporting period, £1,177,183 (CAD$
2,000,000) was provided to Rome in January 2024 as the second and
final drawdown on the loan facility agreed as part of the Proposed
Acquisition.
Board changes
During the reporting period, there
were several changes at board level, reflecting the changes in the
business going forward. Peter Taylor stepped down from the board of
Pathfinder on 22 June 2023 along with Dennis Edmonds on 16 August
2023. I was appointed at the same time and following the
commencement of discussions with Rome Resources and took over the
role of Chief Executive Officer of Pathfinder with Mark Gasson
remaining a non-executive director.
Additionally in November 2023, David
Taylor stepped down from the role of Company Secretary and the role
was taken over by Silvertree Partners.
Outlook
The outlook for the Company is
significantly better than that was the case a year ago. The
disposal of IM Minerals and the potential for future value for
shareholders has allowed the Company to move to the next stage of
its development and with a sub-Saharan metals focus, the Company
has landed on Rome Resources as a reverse takeover candidate,
potentially giving shareholders exposure to a high-quality tin
project. Tin has recently attracted attention as a somewhat
overlooked critical metal with many commentators predicting a
supply squeeze in the coming years.
We believe this project offers
shareholders an excellent opportunity to see significant returns.
The Rome Resources' management were responsible for the world class
Alphamin tin project just 8km from the Rome project and bring a
wealth of knowledge and experience which will be invaluable in the
development of the project.
Paul Barrett
Executive Director
7 May 2024
Consolidated Statement of Comprehensive
Income
for
the Year
Ended 31 December
2023
|
Note
|
Year ended
31 December 2023
|
Year
ended
31 December 2022
|
|
|
£'000
|
£'000
|
CONTINUING
OPERATIONS
|
|
|
|
Revenue
|
|
-
|
-
|
Administrative expenses
|
3,
4
|
(1,043)
|
(376)
|
|
|
|
|
OPERATING LOSS
|
|
(1,043)
|
(376)
|
|
|
|
|
LOSS BEFORE INCOME TAX
|
|
(1,043)
|
(376)
|
Income
tax
|
5
|
-
|
-
|
|
|
|
|
LOSS AFTER INCOME TAX
|
|
(1,043)
|
(376)
|
|
|
|
|
Gain on sale of
investment
|
17
|
1,000
|
-
|
|
|
|
|
LOSS FOR
THE YEAR
|
|
(43)
|
(376)
|
Total comprehensive loss for the
year attributable to equity holders of the parent
|
|
(43)
|
(376)
|
|
|
|
|
Loss per
share
from continuing operations in pence per share:
|
7
|
|
|
Basic and
diluted
|
|
(0.01)
|
(0.07)
|
Consolidated Statement of Financial
Position
for
the Year
Ended 31 December
2023
|
Note
|
Year ended
31 December 2023
|
Year
ended
31 December 2022
|
|
|
£'000
|
£'000
|
NON-CURRENT ASSETS
|
|
|
|
Investments
|
8
|
-
|
-
|
|
|
|
|
CURRENT ASSETS
|
|
|
|
Trade and other
receivables
|
9
|
389
|
13
|
Cash and cash
equivalents
|
10
|
1,396
|
46
|
|
|
|
|
TOTAL ASSETS
|
|
1,785
|
59
|
|
|
|
|
EQUITY AND LIABILITIES
|
|
|
|
Capital and reserves
attributable to equity holders of the Company:
|
|
|
|
Share capital
|
11
|
18,817
|
18,717
|
Share premium
|
11
|
14,613
|
14,239
|
Share based payment
reserve
|
|
42
|
162
|
Shares to issue reserve
|
11
|
1,215
|
-
|
Warrant reserve
|
|
11
|
104
|
Accumulated deficit
|
|
(33,180)
|
(33,357)
|
TOTAL EQUITY
|
|
1,518
|
(135)
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
Trade and other
payables
|
12
|
267
|
114
|
Borrowings
|
13
|
-
|
80
|
TOTAL LIABILITIES
|
|
267
|
194
|
|
|
|
|
TOTAL EQUITY AND LIABILITIES
|
|
1,785
|
59
|
The financial
statements were approved for
issue by the Board of Directors on 7 May 2024 and
were signed on its behalf by:
Paul Barrett
Director
Consolidated Statement of Changes in Equity
for
the Year
Ended 31 December
2023
|
Called up share
capital
|
Share
premium
|
Share based payment
reserve
|
Warrant
reserve
|
Shares to issue
reserve
|
Accumulated
deficit
|
Total
equity
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Balance
at 1 January 2022 as previously stated
|
18,716
|
14,234
|
199
|
255
|
-
|
(33,169)
|
235
|
Loss for
the year
|
-
|
-
|
-
|
-
|
-
|
(376)
|
(376)
|
Total
comprehensive loss for the year
|
-
|
-
|
-
|
-
|
-
|
(376)
|
(376)
|
Issue of
share capital
|
1
|
5
|
-
|
-
|
-
|
-
|
6
|
Cost of
share issue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Share
based payments
|
-
|
-
|
(37)
|
(151)
|
-
|
188
|
-
|
Balance at 31 December
2022
|
18,717
|
14,239
|
162
|
104
|
-
|
(33,357)
|
(135)
|
Loss for the
year
|
-
|
-
|
-
|
-
|
-
|
(43)
|
(43)
|
Total comprehensive loss for
the year
|
-
|
-
|
-
|
-
|
-
|
(43)
|
(43)
|
Issue of share
capital
|
100
|
400
|
-
|
-
|
-
|
-
|
500
|
Cost of share
issue
|
-
|
(25)
|
-
|
-
|
-
|
-
|
(25)
|
Shares to
issue
|
-
|
-
|
-
|
-
|
1,215
|
-
|
1,215
|
Share based
payments
|
-
|
(1)
|
(120)
|
(93)
|
-
|
220
|
6
|
Balance at 31 December
2023
|
18,817
|
14,613
|
42
|
11
|
1,215
|
(33,180)
|
1,518
|
Consolidated Statement of Cash Flows
for
the Year
Ended 31 December
2023
|
Note
|
Year ended
31 December 2023
|
Year
ended
31 December 2022
|
|
|
£'000
|
£'000
|
Cash flows from operating activities
|
|
|
|
Loss before tax
|
|
(43)
|
(376)
|
|
|
|
|
Adjustments for:
|
|
|
|
Finance income
|
|
(7)
|
-
|
Finance expense
|
|
9
|
-
|
Share-based payments
|
|
6
|
-
|
Funds received for disposal of
assets
|
17
|
(1,000)
|
-
|
Net cash flow from operating activities before changes in
working capital
|
|
(1,035)
|
(376)
|
|
|
|
|
Changes in working capital:
|
|
|
|
Increase in trade and other
payables
|
12
|
154
|
6
|
Increase in trade and other
receivables
|
9
|
(376)
|
(35)
|
Net cash flow used in operating activities
|
|
(1,257)
|
(405)
|
|
|
|
|
Cash flow from investing activities
|
|
|
|
Interest received
|
|
7
|
-
|
Gain on disposal of
assets
|
17
|
1,000
|
-
|
Net cash flow from investing activities
|
|
1,007
|
-
|
|
|
|
|
Cash flow from financing activities
|
|
|
|
Proceeds arising as a result of
the issue of ordinary shares
|
|
500
|
6
|
Costs related to issue of ordinary
share capital
|
|
(26)
|
-
|
Shares to issue
|
11
|
1,215
|
-
|
Repayment of borrowings
|
13
|
(80)
|
80
|
Finance expense
|
|
(9)
|
-
|
Net cash flow from financing activities
|
|
1,600
|
86
|
|
|
|
|
Net increase in cash and cash equivalents in the
year
|
|
1,350
|
(319)
|
Cash and cash equivalents at
beginning of the year
|
|
46
|
365
|
Cash and cash equivalents at end
of the year
|
10
|
1,396
|
46
|
Company Statement of Financial Position
for
the Year
Ended 31 December
2023
|
Note
|
Year ended
31 December 2023
|
Year
ended
31 December 2022
|
|
|
£'000
|
£'000
|
NON-CURRENT ASSETS
|
|
|
|
Investments
|
8
|
-
|
-
|
|
|
|
|
CURRENT ASSETS
|
|
|
|
Trade and other
receivables
|
9
|
389
|
13
|
Cash and cash
equivalents
|
10
|
1,396
|
46
|
|
|
|
|
TOTAL ASSETS
|
|
1,785
|
59
|
|
|
|
|
EQUITY AND LIABILITIES
|
|
|
|
Capital and reserves
attributable to equity holders of the Company:
|
|
|
|
Share capital
|
11
|
18,817
|
18,717
|
Share premium
|
11
|
14,613
|
14,239
|
Share based payment
reserve
|
|
42
|
162
|
Warrant reserve
|
|
11
|
104
|
Shares to issue reserve
|
11
|
1,215
|
-
|
Accumulated deficit
|
|
(33,180)
|
(33,357)
|
TOTAL EQUITY
|
|
1,518
|
(135)
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
Trade and other
payables
|
12
|
267
|
114
|
Borrowings
|
13
|
-
|
80
|
TOTAL LIABILITIES
|
|
267
|
194
|
|
|
|
|
TOTAL EQUITY AND LIABILITIES
|
|
1,785
|
59
|
The Company has taken exemptions allowed under
section 408 of the Companies Act 2006 and has not presented its own
profit and loss account in these financial statements. The loss
after tax of the parent Company for the year was £43k (2022:
£376k).
The financial statements were approved and
authorised for issue by the Board of Directors on 7 May 2024 and
were signed on its behalf by:
Paul Barrett
Director
Company Statement of Changes in Equity
for
the Year
Ended 31 December
2023
|
Called up share
capital
|
Share
premium
|
Share based payment
reserve
|
Warrant
reserve
|
Shares to issue
reserve
|
Accumulated
deficit
|
Total
equity
|
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
|
Balance at 1 January
2022
|
18,716
|
14,234
|
199
|
255
|
-
|
(33,169)
|
235
|
|
Loss for the year
|
-
|
-
|
-
|
-
|
-
|
(376)
|
(376)
|
|
Total comprehensive loss for the
year
|
-
|
-
|
-
|
-
|
-
|
(376)
|
(376)
|
|
Issue of
share capital
|
1
|
5
|
-
|
-
|
-
|
-
|
6
|
|
Cost of
share issue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Share
based payments
|
-
|
-
|
(37)
|
(151)
|
-
|
188
|
-
|
|
Balance at 31 December 2022
|
18,717
|
14,239
|
162
|
104
|
-
|
(33,357)
|
(135)
|
|
Loss for the year
|
-
|
-
|
-
|
-
|
-
|
(43)
|
(43)
|
|
Total comprehensive loss for the year
|
-
|
-
|
-
|
-
|
-
|
(43)
|
(43)
|
|
Issue of share capital
|
100
|
400
|
-
|
-
|
-
|
-
|
500
|
|
Cost of share issue
|
-
|
(25)
|
-
|
-
|
-
|
-
|
(25)
|
|
Shares to issue
|
-
|
-
|
-
|
-
|
1,215
|
-
|
1,215
|
|
Share based payments
|
-
|
(1)
|
(120)
|
(93)
|
-
|
220
|
6
|
|
Balance at 31 December 2023
|
18,817
|
14,613
|
42
|
11
|
1,215
|
(33,180)
|
1,518
|
Company Statement of Cash Flows
for
the Year
Ended 31 December
2023
|
Note
|
Year ended
31 December 2023
|
Year
ended
31 December 2022
|
|
|
£'000
|
£'000
|
Cash flows from operating activities
|
|
|
|
Loss before tax
|
|
(43)
|
(376)
|
|
|
|
|
Adjustments for:
|
|
|
|
Finance income
|
|
(7)
|
-
|
Finance expense
|
|
9
|
-
|
Share-based payments
|
|
6
|
-
|
Funds received for disposal of
assets
|
17
|
(1,000)
|
-
|
Net cash flow from operating activities before changes in
working capital
|
|
(1,035)
|
(376)
|
|
|
|
|
Changes in working capital:
|
|
|
|
Increase in trade and other
payables
|
12
|
154
|
6
|
Increase in trade and other
receivables
|
9
|
(376)
|
(35)
|
Net cash flow used in operating activities
|
|
(1,257)
|
(405)
|
|
|
|
|
Cash flow from investing activities
|
|
|
|
Interest received
|
|
7
|
-
|
Gain on disposal of
assets
|
17
|
1,000
|
-
|
Net cash flow from investing activities
|
|
1,007
|
-
|
|
|
|
|
Cash flow from financing activities
|
|
|
|
Proceeds arising as a result of
the issue of ordinary shares
|
|
500
|
6
|
Costs related to issue of ordinary
share capital
|
|
(26)
|
-
|
Shares to issue
|
11
|
1,215
|
|
Repayment of borrowings
|
13
|
(80)
|
80
|
Finance expense
|
|
(9)
|
-
|
Net cash flow from financing activities
|
|
1,600
|
86
|
|
|
|
|
Net increase in cash and cash equivalents in the
year
|
|
1,350
|
(319)
|
Cash and cash equivalents at
beginning of the year
|
|
46
|
365
|
Cash and cash equivalents at end
of the year
|
10
|
1,396
|
46
|
Notes to the
Consolidated Financial Statements
for the year
ended 31 December 2023
1.
ACCOUNTING
POLICIES
General information
Pathfinder Minerals Plc is a public limited
company, quoted on AIM and is incorporated, registered and
domiciled in England.
The Company's registered office is 35 Berkeley
Square, London, England, W1J 5BF.
Basis
of preparation
These financial statements have been prepared
in accordance with UK-adopted International Accounting Standards as
issued by the International Accounting Standards Board (IASB) and
Interpretations (collectively IASs) and with those parts of the
Companies Act 2006 applicable to companies reporting under IASs.
The financial statements have been prepared under the historical
cost convention. The functional and presentational currency of the
Company is Pound Sterling.
New
standards, amendments and interpretations adopted by the
Company
At the date of authorisation of these
financial statements, the following standards and interpretations
relevant to the Company and which have not been applied in these
financial statements, were in issue but were not yet
effective.
Standard
|
Effective date, annual period beginning on or
after
|
IAS 1: Non-current liabilities with covenants
|
1 January 2024
|
IAS 1: Classifications of current
or non-current liabilities
|
1 January 2024
|
IAS 7 and IFRS 7: Supplier finance
arrangements
|
1 January 2024
|
IFRS 16 Leases: Lease liability in
a Sale and Leaseback
|
1 January 2024
|
IAS 21: Lack of
exchangeability
|
1 January 2025
|
The adoption of these standards is not
expected to have any material impact on the financial statements of
the Company.
Going concern
In determining whether these
financial statements should be prepared on the going concern basis,
the Directors must consider whether the business has adequate
financial resources to continue to operate and meet its obligations
for a period of at least 12 months from the date of this
report.
The Directors have assessed the
funding needs of the business as it continues to progress the
Proposed Acquisition with Rome Resources, together with the various
forms of funding that remain available to it, including but not
limited to the allotment of new ordinary shares for cash and the
drawing of other forms of finance such as convertible debt
instruments. Following consideration of the timing of costs
associated with the continued efforts to complete the transaction,
coupled with the assessment of the funding options that remain
available as this process continues, the Directors have determined
that sufficient funding remains available for the Company to
continue to meet its obligations as they fall due over the course
of this process. However, as the company does not have
an ability to generate revenue and the timings around this are
currently uncertain, a material uncertainty exists as to the
Company's ability to then raise additional equity or debt funding
based on conditions in existence at the appropriate time. The
auditors have included a material uncertainty in the their audit
report due to circumstances noted above.
The Directors believe that the
Company has adequate financial resources available to continue its
operational existence for at least 12 months from the date of the
approval of these financial statements. Accordingly, the Directors
believe that it is appropriate to continue to adopt the going
concern basis in preparing these financial statements.
Basis of
consolidation
Although the Company's direct subsidiary as at
31 December 2022, IM Minerals Limited holds 99.9% of the issued
share capital of Companhia Mineira de Naburi SARL, which in turn
holds 99.8% of the issued share capital of Sociedade Geral de
Mineracao de Moçambique SARL, events in 2011 indicated that the
Company does not control either of these
Moçambique-domiciled companies group companies;
neither has it been possible to obtain the statutory registers or
audited accounts for them; accordingly, these financial statements
consolidate the financial statements of IM Minerals Limited only.
IM Minerals Limited is a dormant intermediate holding company
registered in England & Wales. In July 2023 the Company sold
its holdings in IM Minerals Limited and its subsidiaries to Acumen
Advisory Group LLC along with the rights to bring a claim against
the government of Mozambique. As a consequence of this
divestment, the Company no longer consolidates the performance of
IM Minerals Limited.
Foreign
currencies
Assets and liabilities in foreign currencies
are translated into sterling at the rates of exchange ruling at the
statement of financial position date. Transactions in foreign
currencies are translated into sterling at the rate of exchange
ruling at the date of transaction. Exchange differences are
considered in arriving at the operating result.
Employee
benefit costs
The Group makes available a defined
contribution pension scheme to eligible employees. Any
contributions paid to the Group's pension scheme are charged to the
income statement in the period to which they relate.
Equity
instruments and reserves description
An equity instrument is any contract that
evidences a residual interest in the assets of the Company after
deducting all of its liabilities. Equity instruments issued by the
Company are recorded at the proceeds received net of direct issue
costs.
Ordinary shares are classified as
equity.
Deferred shares are classified as equity but
have restricted rights such that they have no economic
value.
Share capital account represents the nominal
value of the ordinary and deferred shares issued.
The share premium account represents premiums
received on the initial issuing of the share capital. Any
transaction costs associated with the issuing of shares are
deducted from share premium, net of any related income tax
benefits.
Share based payment reserve represents
equity-settled share-based employee remuneration until such share
options are exercised.
Warrant reserve represents equity-settled
share-based payments until such share warrants are
exercised.
The shares to issue reserve represents the
total value of funds received in the year for issuance of share
capital issued post reporting period end to which the price and
number of shares are fixed.
Share-based
payments
Where equity settled share options or warrants
are awarded, the fair value of the options at the date of grant is
charged to the statement of comprehensive income over the vesting
period. Non-market vesting conditions are considered by
adjusting the number of equity instruments expected to vest at each
balance sheet date so that, ultimately, the cumulative amount
recognised over the vesting period is based on the number of
options that eventually vest.
Financial
instruments
Trade and other
receivables
Trade receivables are measured at initial
recognition at fair value and are subsequently measured at
amortised cost using the effective interest rate method. Trade and
other receivables are accounted for at original invoice amount less
any provisions for doubtful debts. Provisions are made where
there is evidence of a risk of non-payment, considering the age of
the debt, historical experience and general economic
conditions. If a trade debt is determined to be
uncollectable, it is written off, firstly against any provisions
already held and then to the statement of comprehensive
income. Subsequent recoveries of amounts previously provided
for are credited to the statement of comprehensive
income.
Appropriate allowances for estimated
irrecoverable amounts are recognised in profit or loss in
accordance with the expected credit loss model under IFRS 9. For
trade and other receivables which do not contain a significant
financing component, the Company applies the simplified approach.
This approach requires the allowance for expected credit losses to
be recognised at an amount equal to lifetime expected credit
losses. For other debt financial assets, the Company applies the
general approach to providing for expected credit losses as
prescribed by IFRS 9, which permits for the recognition of an
allowance for the estimated expected loss resulting from default in
the subsequent 12-month period. Exposure to credit loss is
monitored on a continual basis and, where material, the allowance
for expected credit losses is adjusted to reflect the risk of
default during the lifetime of the financial asset should a
significant change in credit risk be identified.
The majority of the Company's financial assets
are expected to have a low risk of default. A review of the
historical occurrence of credit losses indicates that credit losses
are insignificant due to the size of the Company's clients and the
nature of its activities. The outlook for the natural resources
industry is not expected to result in a significant change in the
Company's exposure to credit losses. As lifetime expected credit
losses are not expected to be significant the Company has opted not
to adopt the practical expedient available under IFRS 9 to utilise
a provision matrix for the recognition of lifetime expected credit
losses on trade receivables. Allowances are calculated on a
case-by-case basis based on the credit risk applicable to
individual counterparties.
Trade and other
payables
Trade and other payables are held at amortised
cost which equates to nominal value.
Cash and cash
equivalents
Cash and cash equivalents comprise cash in
hand, current balances with banks and similar institutions and
liquid investments generally with maturities of 3 months or
less. They are readily convertible into known amounts of cash
and have an insignificant risk of changes in values.
Taxation
The tax expense represents the sum of the tax
currently payable and deferred tax.
The tax currently payable is based on taxable
profit for the period. Taxable profit differs from the net
profit as reported in the income statement because it excludes
items of income or expense that are taxable or deductible in other
periods and it further excludes items that are never taxable or
deductible. The Company's liability for current tax is
calculated using tax rates that have been enacted or substantively
enacted by the balance sheet date.
Provisions
Provisions are recognised when the Company has
a present obligation as a result of a past event, it is probable
that the Company will be required to settle that obligation and a
reliable estimate can be made of the amount of the
obligation. The amount recognised as a provision is the best
estimate of the consideration required to settle the present
obligation at the balance sheet date, taking into account the risks
and uncertainties surrounding the obligation.
Critical
accounting estimates and judgements
The preparation of financial information in
accordance with generally accepted accounting practice, in the case
of the Group using IFRSs, requires the directors to make estimates
and judgements that affect the reported amount of assets,
liabilities, income and expenditure and the disclosures made in the
financial statements. Such estimates and judgements must be
continually evaluated based on historical experience and other
factors, including expectations of future events.
Details of accounting estimates and judgements
that have the most significant effect on the amounts recognised in
the financial statements have been disclosed under the relevant
note or accounting policy for each area where disclosure is
required.
Valuation of
share-based payments to employees
The Company estimates the expected value of
share-based payments to employees and this is charged through the
income statement over the vesting period. The fair value is
estimated using the Black Scholes valuation model which requires a
number of assumptions to be made such as level of share vesting,
time of exercise, expected length of service and employee turnover
and share price volatility. This method of estimating the
value of share-based payments is intended to ensure that the actual
value transferred to employees is provided for by the time such
payments are made.
Recovery of
loan to Rome Resources Ltd
As announced on 29 November 2023, the Company
has entered into a proposed acquisition agreement to acquire the
entire share capital of Rome Resources Ltd ("Rome"). The
Company has entered into a loan agreement with Rome to fund the
acquisition process, providing a total of CAD2,500,000 to Rome over
the course of the transaction completion process. As at the
reporting date, the amount of CAD500,000 had been provided to Rome
and which is carried in these financial statements at £299,000 as a
non-current asset receivable. Recovery of this receivable
remains contingent on the completion of the proposed
transaction. The directors are of the opinion that completion
of the proposed transaction is highly probable and as there is no
indication that the loan receivable from Rome may not be recovered,
no impairment has been recognised as regards this asset.
2.
SEGMENTAL
REPORTING
The Group has one activity only. The whole of
the value of the Group's and the Company's net assets in their
respective financial statements at 31 December 2023 and 2022 was
attributable to UK assets and liabilities.
3.
OPERATING
LOSS
Group and Company
|
2023
|
2022
|
|
£'000
|
£'000
|
Loss from operations has been arrived
at after charging:
|
|
|
Directors' Remuneration
|
219
|
124
|
Share based payment charge
|
6
|
-
|
Legal Fees
|
270
|
4
|
Nomad Fees
|
45
|
50
|
Fees payable to the Company's auditor for the audit of the
Group and Company's financial statements
|
26
|
22
|
4.
EMPLOYEES AND DIRECTORS
The average number of persons employed by the
Company in the financial year (including directors that receive
remuneration) was 4 (2022: 5).
The highest paid director during the year
received £130,000 (2022: 62,000).
The following tables set out and analyse the remuneration of directors for the years ended 31 December 2023 and
2022.
For the year ended 31 December
2023:
|
Salary
|
Fees
|
Total
emoluments
|
Contribution to Pension
schemes
|
Share Based
Payments
|
Total
remuneration
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Dennis Edmonds
|
56
|
-
|
56
|
-
|
-
|
56
|
Peter Taylor
|
125
|
-
|
125
|
1
|
4
|
130
|
Mark Gasson
|
-
|
28
|
28
|
-
|
1
|
29
|
Paul Barrett
|
10
|
-
|
10
|
-
|
-
|
10
|
|
191
|
28
|
219
|
1
|
5
|
225
|
For the year ended 31 December
2022:
|
Salary
|
Fees
|
Total
emoluments
|
Contribution to Pension
schemes
|
Share Based
Payments
|
Total
remuneration
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Dennis Edmonds
|
30
|
-
|
30
|
-
|
-
|
30
|
Peter Taylor
|
60
|
-
|
60
|
2
|
-
|
62
|
Mark Gasson
|
-
|
25
|
25
|
-
|
-
|
25
|
Jonathan Summers
|
7
|
-
|
7
|
-
|
-
|
7
|
|
97
|
25
|
122
|
2
|
-
|
124
|
No share options were exercised by the
directors, and no shares were received or receivable by any
director in respect of qualifying services under a long-term
incentive scheme.
5.
INCOME
TAX
The charge for the year is made up as
follows:
|
2023
|
2022
|
|
£'000
|
£'000
|
Current tax
|
-
|
-
|
Tax charge for the year
|
-
|
-
|
Analysis of tax expense
No liability to UK corporation tax arose for the year ended 31 December 2023 nor
for the
year ended 31 December 2022. No deferred tax asset has been
recorded on tax losses carried forward.
Factors
affecting
the tax
expense
The tax assessed for the year is higher than (2022: higher than)
the standard rate of corporation tax in the UK. The difference
is explained below:
|
2023
|
2022
|
|
£'000
|
£'000
|
Loss on ordinary activities before
tax
|
(43)
|
(376)
|
Loss on ordinary activities
multiplied by the standard rate of corporation tax in the UK of 19%
(2022: 19%)
|
(8)
|
(71)
|
Effects of:
|
|
|
Non-deductible expenses
|
-
|
-
|
Income not chargeable to tax
|
-
|
-
|
Unrelieved tax losses carried forward
|
8
|
71
|
Tax expense
|
-
|
-
|
6.
LOSS OF PARENT COMPANY
As permitted by Section 408 of the Companies
Act 2006, the income statement of the parent company is not
presented as part of these financial statements. The parent company's loss for the financial year was
£43k (2022: £376k).
7.
LOSS PER SHARE
Basic loss per share is calculated, as set out in the tables below, by dividing the loss attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.
In accordance with IAS 33, as the Group is
reporting a loss for both this and the preceding year the share
options
and warrants are not considered dilutive
because the exercise of these would have the effect of reducing the
loss per share.
As at 31 December 2022:
|
|
|
|
|
Loss
£'000
|
Weighted average number of
shares
|
Per-share amount,
pence
|
Basic loss attributable to the
ordinary shareholders
|
376
|
532,094,193
|
0.07p
|
|
|
|
|
As at 31 December 2023:
|
|
|
|
|
Loss
£'000
|
Weighted average number of
shares
|
Per-share amount,
pence
|
Basic loss attributable to the
ordinary shareholders
|
43
|
623,727,711
|
0.01p
|
8.
INVESTMENTS
Parent
company
|
Shares in group undertakings
£'000
|
COST
|
|
At 1 January 2022 and 1 January 2023
|
34,806
|
|
|
Disposal of subsidiaries in the year
|
(34,806)
|
|
|
PROVISION FOR
IMPAIRMENT
|
|
At 1 January 2022 and 1 January 2023
|
(34,806)
|
|
|
Reversal of impairment on disposal in the year
|
34,806
|
|
|
NET BOOK
VALUE
|
|
At 31 December 2022 and 31 December 2023
|
-
|
Subsidiaries
Pathfinder Battery Commodities
Ltd
Registered office: 35 Berkeley Square,
London, W1J 5BF, United Kingdom
Nature of business: Holding company
Class of shares:
Ordinary
Holding:
100.00%
Incorporated:
20 May
2022
IM Minerals Limited held the shares in Companhia Mineira de Naburi SARL ("CMdN") which held titanium dioxide mining concessions in the Republic of Mozambique. In November 2011, the original vendors of IM Minerals' subsidiary, CMdN, advised the Company that they had procured the cancellation of IM Minerals Ltd's shares in CMdN and the transfer of its assets (the mining licences) to another company controlled by them. Whilst the Company is taking legal and other action in order to recover the shares and the licences, the Company, in the interest of accounting prudence, made full provision in the 2011 financial statements against the cost of its investment
in IM Minerals
Ltd. As a consequence of the situation regarding the
Company's legal claims, the Company has been unable to verify the
current registered office addresses for the Mozambique-domiciled
companies, CMdN and Sociedade Geral de Mineracao de Moçambique
SARL. Furthermore, whilst the Company believes these companies to
be non-trading, the Company has been unable to verify their trading
statuses.
On 28 July 2023 Pathfinder Minerals Plc sold
100% of its position to Acumen Advisory Group LLC along with its
rights to bring a claim against the Government of Mozambique for
initial consideration of £1,000,000. The remaining consideration
consists of a contingent payment of the aggregate amount payable on
settlement or determination of the claim shown in the below
table.
Amount for which Rights Claim
Finalised (US$M)
|
Percentage of Net Recoveries to be
paid to Pathfinder
|
0 - 10m
|
40.0%
|
10m - 20m
|
37.5%
|
20m - 30m
|
35.0%
|
30m - 40m
|
32.5%
|
40m - 50m
|
30.0%
|
50m - 70m
|
27.5%
|
70m - 120m
|
25.0%
|
>120m
|
22.5%
|
9.
TRADE AND OTHER RECEIVABLES
Current
|
Group
|
|
Parent
Company
|
|
2023
|
2022
|
|
2023
|
2022
|
|
£'000
|
£'000
|
|
£'000
|
£'000
|
Other debtors
|
8
|
8
|
|
8
|
8
|
VAT
|
21
|
5
|
|
21
|
5
|
Prepayments
|
61
|
-
|
|
61
|
-
|
Loan
receivable
|
299
|
-
|
|
299
|
-
|
|
389
|
13
|
|
389
|
13
|
|
|
|
|
|
|
The loan receivable balance of £299k (C$500K)
is owed by Rome Resources, a related party entity as a result of
having a common director.
10.
CASH
AND CASH
EQUIVALENTS
|
Group
|
|
Parent
Company
|
|
2023
|
2022
|
|
2023
|
2022
|
|
£'000
|
£'000
|
|
£'000
|
£'000
|
|
|
|
|
|
|
Bank accounts
|
1,396
|
46
|
|
1,396
|
46
|
11.
SHARE
CAPITAL
a) Called up, allotted,
issued and fully paid share capital
|
No. Ordinary shares of 0.1p
each
|
Deferred shares of 9.9p
each
|
Allotment
price
(£s)
|
Share
Capital
£'000
|
Share
Premium
£'000
|
Shares to Issue
Reserve
£'000
|
Total as at 31 December 2021
|
531,328,168
|
183,688,116
|
|
18,716
|
14,234
|
-
|
6 May 2022
|
1,166,666
|
-
|
0.005
|
1
|
5
|
-
|
Total as at 31 December
2022
|
532,494,834
|
183,688,116
|
|
18,717
|
14,239
|
-
|
1 Feb 2023
|
100,000,000
|
-
|
0.005
|
100
|
374
|
-
|
Total as at 31 December
2023
|
632,494,834
|
183,688,116
|
|
18,817
|
14,613
|
1,215
|
On the 29th November 2023 the
Company allotted 425,000,000 shares for total consideration of
£1,275,000 net of associated costs. As at year end £60,000 remained
outstanding from investors with £1,215,000 having been received in
the year. This issuance was subject to shareholder approval which
was obtained January 2024 and as a result these shares were issued
subsequent to the year end and the cash received of £1,215,000 is
shown within a shares to be issued reserve as at 31 December
2023.
b) Share options &
warrants in issue
Share
options
Exercise Price
|
Grant Date
|
Expiry Date
|
At 1 January 2023
|
Issued / (lapsed)
|
At 31 December 2023
|
1.25p(1)
|
11 May 2020
|
30 June 2025
|
10,000,000
|
-
|
10,000,000
|
1.25p(1)
|
4 August 2020
|
30 June 2025
|
6,000,000
|
-
|
6,000,000
|
1.75p
|
21 September 2018
|
20 September 2023
|
18,750,000
|
(18,750,000)
|
-
|
0.55p
|
17 March 2021
|
16 March 2023
|
6,000,000
|
(6,000,000)
|
-
|
1.25p
|
1 April 2021
|
31 March 2023
|
6,000,000
|
(6,000,000)
|
-
|
1.25p
|
9 June 2021
|
30 June 2025
|
6,000,000
|
-
|
6,000,000
|
1.25p
|
23 June 2021
|
30 June 2025
|
3,000,000
|
-
|
3,000,000
|
1.25p
|
4 October 2021
|
30 June 2025
|
5,000,000
|
-
|
5,000,000
|
|
|
|
60,750,000
|
(30,750,000)
|
30,000,000
|
(1) On 27 April
2023, the following amendments were made to certain of the above
share options:
· 6,000,000 of the
6,000,000 1.25p options that were otherwise due to expire on 8
August 2023 were extended so as to lapse on 30 June 2025
· 5,000,000 options with
an exercise price of 1.25p and an expiry date of 3 October 2023,
were extended so as to expire on 30 June 2025.
· 6,000,000 options with
an exercise price of 1.25p and an expiry date of 8 June 2023, were
extended so as to expire on 30 June 2025.
· 3,000,000 options with
an exercise price of 1.25p and an expiry date of 22 June 2023, were
extended so as to expire on 30 June 2025.
· 10,000,000 options with
an exercise price of 1.25p and an expiry date of 11 May 2023, were
extended so as to expire on 30 June 2025.
Share
warrants
Exercise Price
|
Expiry Date
|
At 1 January 2023
|
Issued/(lapsed)
|
At 31 December 2023
|
0.50p
|
31 May 2023
|
11,666,668
|
(11,666,668)
|
-
|
1.50p
|
31 May 2023
|
3,076,923
|
(3,076,923)
|
-
|
0.60p
|
29 April 2024
|
3,500,000
|
-
|
3,500,000
|
0.5p(1)
|
31 January 2025
|
-
|
5,000,000
|
5,000,000
|
|
|
18,243,591
|
(9,743,591)
|
8,500,000
|
(1) On 31 January 2023, 5,000,000
warrants over Ordinary shares were issued at a strike price of
0.45p per share, the exercise period is 2 years.
12.
TRADE AND OTHER PAYABLES
|
Group
|
|
Parent
Company
|
|
2023
|
2022
|
|
2023
|
2022
|
|
£'000
|
£'000
|
|
£'000
|
£'000
|
Trade creditors
|
224
|
4
|
|
224
|
4
|
Social security and other
taxes
|
12
|
43
|
|
12
|
43
|
Other creditors
|
-
|
42
|
|
-
|
42
|
Accruals and deferred
income
|
31
|
25
|
|
31
|
25
|
|
267
|
114
|
|
267
|
113
|
13.
BORROWINGS
On 29 September 2022 and 28 December 2022, the
Company announced it has entered into a loan agreement whereby an
FCA authorised financial institution has arranged for the provision
to the Company by an individual, of an unsecured loan facility of
up to £120,000 (the "Loan") for working capital purposes. The Loan
carried a simple fixed interest of 5.0 percent on any amounts drawn
down and had issue costs of £5,000. The Loan was designed to
provide the Company with access to additional working capital,
should it be required. As at 31 December 2022 £80,000 had been
drawn down.
The Loan was repaid in full together with
accrued interest and the issue costs on 1 February 2023.
14.
CONTINGENT LIABILITIES
As at the reporting date, the Company had an
obligation to disburse the second tranche of the loan to Rome
Resources Ltd pursuant to the loan agreement announced on 29
November 2023, totalling C$2,000,000, contingent on receiving a
formally executed drawdown request. Such a drawdown request was
received in January 2024 and consequently disbursement of this
second tranche of the loan took place in January 2024, see note 19
for further details.
15.
RELATED
PARTY DISCLOSURES
· Related
party receivables are disclosed in note 9 and 19.
· Details of directors' remuneration are given in note 4 above.
16.
SHARE BASED PAYMENTS
The fair values of the share options and
warrants at the date of grant have been measured using the Black-
Scholes pricing model, which takes into account factors such as the
option life, share price volatility and the risk-free
rate.
Each share option and warrant vested and was
exercisable immediately upon grant. The share-based expense
relating to each share option and share warrant was recognised in
full on the date of grant.
Share
options
Date
of grant
|
Share price
|
Exercise
price
|
Risk Free
Rate(1)
|
Expected
life
of options
|
Expected
yield
|
Expected
volatility(2)
|
Fair value per
option
|
11 May 2020
|
0.93p
|
1.25p(3)
|
0.07%
|
2
years
|
0%
|
55%
|
£0.00190
|
4 August 2020
|
0.43p
|
1.25p(3)
|
0.06%
|
2
years
|
0%
|
55%
|
£0.00022
|
9 June 2021
|
0.79p
|
1.25p(3)
|
0.05%
|
2
years
|
0%
|
55%
|
£0.00127
|
23 June 2021
|
0.75p
|
1.25p(3)
|
0.05%
|
2
years
|
0%
|
55%
|
£0.00111
|
4 October 2021
|
0.73p
|
1.25p(3)
|
0.05%
|
2
years
|
0%
|
55%
|
£0.00101
|
27 April
2023(4)
|
0.5p
|
0.75p
|
4.18%
|
2.2
years
|
0%
|
55%
|
£0.00107
|
(1) Daily sterling overnight index average (SONIA) rate at the
date of grant was adopted as the effective risk-free rate.
(2) Expected volatility is based on management's estimate of the
expected volatility.
(3) Repriced to 0.75p on 27 April 2023.
(4) Values for repricing model of existing options for FV
adjustment determination.
Share
warrants
Date
of grant
|
Share price
|
Exercise
price
|
Risk Free
Rate
|
Expected
life
of warrants
|
Expected
yield
|
Expected
volatility
|
Fair value per
option
|
21 May 2021
|
0.68p
|
0.6p
|
0.05%
|
2.9
years
|
0%
|
55%
|
£0.00271
|
31 January 2023
|
0.41p
|
0.5p
|
3.45%
|
2
years
|
0&
|
19%
|
£0.00023
|
On 27 April 2023, the Company extended the
expiry date of certain directors' share options and share warrants
issued to a related party. The details are as follows:
Director
|
Date of
Grant
|
No.
Options
|
Exercise
Price
|
Original Expiry
Date
|
New Expiry
Date
|
Dennis Edmonds
|
27/04/2023
|
10,000,000
|
£0.0125
|
11/05/2023
|
30 June
2025
|
Peter Taylor
|
27/04/2023
|
6,000,000
|
£0.0125
|
30/08/2023
|
30 June
2025
|
Peter Taylor
|
27/04/2023
|
5,000,000
|
£0.0125
|
03/10/2023
|
30 June
2025
|
Mark Gasson
|
27/04/2023
|
6,000,000
|
£0.0125
|
08/06/2023
|
30 June
2025
|
David Taylor
|
27/04/2023
|
3,000,000
|
£0.0125
|
22/06/2023
|
30 June
2025
|
The extension of
share options and warrants did not result in a change to the fair
value that was determined on initial recognition.
The
directors' interests in the share options and warrants of the
Company as at 31 December 2023 are as follows:
Director
|
Number of options
|
Number of warrants
|
Exercise price per share
|
Latest exercise date
|
|
|
|
|
|
M Gasson
|
6,000,000
|
-
|
1.25p
|
8 June 2023
|
|
|
|
|
|
The total share-based payment expense in the
year for the Company was £6k in relation to options (2022: £nil)
and £nil in relation to warrants (2022: £nil).
17.
Disposal of IM Minerals Limited ('IMM')
On 28 July 2023 the Company,
completed the disposal of 100% of the shares in IMM, a wholly owned
subsidiary of the Company with Acumen Advisory Group LLC
("AAG").
The gain on disposal in the
consolidated financial statements are as follows:
Carrying value of total identifiable net assets disposed
of
|
-
|
|
|
Total Present Value of consideration
|
1,000
|
|
|
Gain on disposal
|
1,000
|
|
|
Consideration for the disposal of
IMM is receivable in two tranches, being:
·
Tranche 1 - £1,000,000 on completion of the
transaction;
·
Tranche 2 - A contingent payment based on a
sliding recovery scale varying between 40% - 22.5% dependant on the
amount recovered from the claim less reasonable costs incurred as
shown in note 8.
The Company had historically fully impaired all
the fair value of the assets and liabilities of AAG, see note 8 for
further details.
18.
FINANCIAL INSTRUMENTS
The Group and Company's principal
financial instruments comprise cash and cash equivalents and other
receivables/payables. The Company's accounting policies and method
adopted, including the criteria for recognition, the basis on which
income and expenses are recognised in respect of each class of
financial assets, financial liability and equity instrument are set
out in note 1. The Company does not use financial instruments for
speculative purposes.
The principal financial
instruments used by the Company, from which financial instrument
risk arises, are as follows:
|
Group
|
Parent
Company
|
|
2023
|
2022
|
2023
|
2022
|
Financial assets at
amortised cost
|
£'000
|
£'000
|
£'000
|
£'000
|
Cash and
cash equivalents
|
1,396
|
46
|
1,396
|
46
|
Other
debtors
|
29
|
13
|
29
|
13
|
Loans
|
299
|
-
|
299
|
-
|
|
|
|
|
|
Financial liabilities at
amortised cost
|
|
|
|
|
Trade
payables
|
236
|
114
|
236
|
114
|
a)
Financial risk management objectives and policies
The Company's major financial
instruments include bank balances and amounts payable to suppliers.
The risks associated with these financial instruments and the
policies on how to mitigate these risks are set out below. The
Directors manage and monitor these exposures to ensure appropriate
measures are implemented on a timely and effective
manner.
b) Liquidity
risk
Liquidity risk arises from the
Company's management of working capital.
The Company regularly reviews its
major funding positions to ensure that it has adequate financial
resources in meeting its financial obligations. The Directors have
considered the liquidity risk as part of their going concern
assessment (see note 1). Controls over expenditure are carefully
managed in order to maintain its cash reserves whilst it targets a
suitable transaction. Financial liabilities are all due within one
year.
c) Credit
risk
The Company's credit risk is
attributable to its cash and loan balance. The credit risk from its
cash and cash equivalents is limited because the counterparties are
banks with high credit ratings and have not experienced any losses
in such accounts. The Company assesses the creditworthiness of
loans receivable from related parties and establishes appropriate
terms and conditions for loan agreements.
d) Interest
risk
The Company's exposure to interest
rate risk is the interest received on the cash held, which is
immaterial.
e) Capital risk
management
The Company's objectives when
managing capital are to safeguard the Company's ability to continue
as a going concern, in order to provide returns for shareholders
and benefits for other stakeholders and to maintain an optimal
capital structure. The Company has no borrowings. In order to
maintain or adjust the capital structure, the Company may adjust
the amount of dividends paid to shareholders, return capital to
shareholders, or issue new shares.
f) Fair
value of financial assets and liabilities
There are no material differences
between the fair value of the Company's financial assets and
liabilities and their carrying values in the financial
information.
19.
EVENTS AFTER THE REPORTING
PERIOD
The Company and Rome Resources
entered into a non-binding heads of terms providing for the
potential acquisition of the issued and outstanding securities of
Rome by the Company. Related to the Proposed Acquisition,
Pathfinder has agreed to lend the Company up to C$2,500,000 paid in
two drawdowns on an unsecured basis to support its ongoing
exploration activities in the DRC. The first drawdown of C$500k
loan funds have been drawn down at year end.
Under the terms of the Heads of
Terms governing the acquisition of Rome Resources, a loan has been
provided to Rome to support its exploration programme in a tin and
related metals prospect in the Bisie North area of the North Kivu
district of the Democratic Republic of Congo ('DRC'). The
terms of this loan facility are a maximum facility of C$2,500,000
which, when fully drawn down, triggers the issue of 10,000,000
warrants in Rome Resources to the Company, exercisable at C$0.25
per share. A fixed payment of 10% is attached to the loan,
except in the case of termination, when it will be 15%. The
loan becomes repayable to the Company on the first anniversary of
full drawdown, ie 12th January 2025.
As at year end the second drawdown
of C$2,000,000 remains unpaid, being paid in full January
2024.
On the 29th November 2023 the
Company allotted 425,000,000 shares for total consideration of
£1,275,000 net of associated costs and warrants of 212,500,000 with
an exercise price of £0.0045. This issuance was subject to
shareholder approval which was obtained January 2024. As a result
these shares were issued subsequent to the year end.
20.
ULTIMATE CONTROLLING PARTY
The directors believe there is no ultimate controlling
party.